However, in contrast to other well-defined interferonopathies such as Aicardi–Goutières syndrome (AGS) or STING-associated vasculopathy with onset in infancy (SAVI), the molecular mechanisms leading to type I IFN production in PRAAS remain unclear. The gene discussed is STING1; the disease is Aicardi-Goutieres syndrome.